✦ LIBER ✦

T-47 Thrombocytopenia and neutropenia during peginterferon plus ribavirin combination therapy in cirrhotic patients with HCV infection

✍ Scribed by A. Iacobellis; M.R. Valvano; N. Minerva; R. Cozzolongo; G.A. Niro; A. Andriulli

Book ID: 118648302
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 59 KB
Volume: 44
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(12)60084-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bacterial infection and neutropenia duri

Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice

✍ J.-F. YANG; M.-Y. HSIEH; N.-J. HOU; C.-Y. DAI; J.-F. HUANG; Z.-Y. LIN; S.-C. CHE 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

An early viral response to standard inte

An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1

✍ Hidenori Toyoda; Takashi Kumada; Seiki Kiriyama; Makoto Tanikawa; Yasuhiro Hisan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

## Abstract As combination therapy with peginterferon (PEG‐IFN) and ribavirin has a high morbidity, identifying individuals with hepatitis C virus (HCV) who will not respond to the treatment would be beneficial. The early responses of serum HCV RNA levels to standard interferon (IFN) and PEG‐IFN we

433 FREQUENCIES OF RESISTANCE-ASSOCIATED

433 FREQUENCIES OF RESISTANCE-ASSOCIATED AMINO ACID VARIANTS DETECTED BY 454-SEQUENCING DURING COMBINATION TREATMENT WITH BOCEPREVIR PLUS PEGINTRON (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN HCV (GT1)-INFECTED PATIENTS

✍ J.A. Howe; P. Qiu; R.A. Ogert; P. Mendez; C.A. Brass; J. Albrecht; R. Ralston; R 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

T-cell responses at baseline and during

T-cell responses at baseline and during therapy with peginterferon-α and ribavirin are not associated with outcome in chronic hepatitis C infected patients

✍ Joop E. Arends; Mark A.A. Claassen; Charlotte H.S.B. van den Berg; Nening M. Nan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 403 KB

Predictive value of early viral dynamics

Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b

✍ Hidenori Toyoda; Takashi Kumada; Toshifumi Tada; Kazuhiko Hayashi; Takashi Honda 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 1 views

## Abstract A study was carried out to determine whether early viral dynamics retain prediction of the outcome of peginterferon (PEG‐IFN) and ribavirin combination therapy based on different genetic polymorphisms near the __IL28B__ gene, the strongest baseline predictor of response to this therapy.

Mutation frequency of NS5A in patients v

Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy

✍ A. C. W. Jenke; S. Moser; V. Orth; M. Zilbauer; P. Gerner; S. Wirth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB